SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite Pharma, Inc. (Nasdaq:KITE) today announced that 82 percent of patients (9 out of 11) achieved complete remission or complete remission with incomplete or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback